Sai Sadhananth Srinivasan

Sai Sadhananth Srinivasan

Auto-generated profile, based on publicly available information

Sai Sadhananth Srinivasan

Nebraska Translational Research Center (NTRC) Department of Growth and Development College of Dentistry University of Nebraska Medical Center Omaha, NE 68105, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2024 in Gels
Verified
Journal Article
Open access
PDF file
SDShivam U Desai
Shivam U Desai
SSSai Sadhananth Srinivasan
Sai Sadhananth Srinivasan
Sangmesh KumbarSangmesh Kumbar
Sangmesh Kumbar
IMIsaac L Moss
Isaac L Moss
Millions of people worldwide suffer from low back pain and disability associated with intervertebral disc (IVD) degeneration. IVD degeneration is highly correlated with aging, as the nucleus pulposus (NP) dehydrates and the annulus fibrosus (AF) fissures form, which often results in intervertebral disc herniation or disc space collapse and related clinical symptoms. Currently available options for treating intervertebral disc degeneration are symptoms control with therapy modalities, and/or medication, and/or surgical resection of the IVD with or without spinal fusion. As such, there is an urgent clinical demand for more effective disease-modifying treatments for this ubiquitous disorder, rather than the current paradigms focused only on symptom control. Hydrogels are unique biomaterials that have a variety of distinctive qualities, including (but not limited to) biocompatibility, highly adjustable mechanical characteristics, and most importantly, the capacity to absorb and retain water in a manner like that of native human nucleus pulposus tissue. In recent years, various hydrogels have been investigated in vitro and in vivo for the repair of intervertebral discs, some of which are ready for clinical testing. In this review, we summarize the latest findings and developments in the application of hydrogel technology for the repair and regeneration of intervertebral discs.

12 March 2008 in Diabetologia
Verified
Journal Article
Open access
PDF file
PTPaolo Tammaro
Paolo Tammaro
SFSarah Flanagan
Sarah Flanagan
BZB. Zadek
B. Zadek
SSS. Srinivasan
S. Srinivasan
HWH. Woodhead
H. Woodhead
FAF. M. Ashcroft
F. M. Ashcroft
Heterozygous activating mutations in the pancreatic ATP-sensitive K+ channel cause permanent neonatal diabetes mellitus (PNDM). This results from a decrease in the ability of ATP to close the channel, which thereby suppresses insulin secretion. PNDM mutations that cause a severe reduction in ATP inhibition may produce additional symptoms such as developmental delay and epilepsy. We identified a heterozygous mutation (L164P) in the pore-forming (Kir6.2) subunit of the channel in three unrelated patients and examined its functional effects. The patients (currently aged 2, 8 and 20 years) developed diabetes shortly after birth. The two younger patients attempted transfer to sulfonylurea therapy but were unsuccessful (up to 1.1 mg kg−1 day−1). They remain insulin dependent. None of the patients displayed neurological symptoms. Functional properties of wild-type and mutant channels were examined by electrophysiology in Xenopus oocytes. Heterozygous (het) and homozygous L164P KATP channels showed a marked reduction in channel inhibition by ATP. Consistent with its predicted location within the pore, L164P enhanced the channel open state, which explains the reduction in ATP sensitivity. HetL164P currents exhibited greatly increased whole-cell currents that were unaffected by sulfonylureas. This explains the inability of sulfonylureas to ameliorate the diabetes of affected patients. Our results provide the first demonstration that mutations such as L164P, which produce a severe reduction in ATP sensitivity, do not inevitably cause developmental delay or neurological problems. However, the neonatal diabetes of these patients is unresponsive to sulfonylurea therapy. Functional analysis of PNDM mutations can predict the sulfonylurea response.

17 November 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
MTMadhumithra Thangadurai
Madhumithra Thangadurai
SSSai Sadhananth Srinivasan
Sai Sadhananth Srinivasan
MSMuthu Parkkavi Sekar
Muthu Parkkavi Sekar
SSSwaminathan Sethuraman
Swaminathan Sethuraman
DSDhakshinamoorthy Sundaramurthi
Dhakshinamoorthy Sundaramurthi
3D printed/bioprinted tissue constructs are utilized for the regeneration of damaged tissues and as in vitro models. Most of the fabricated 3D constructs fail to undergo functional maturation in conventional in vitro settings. There is a challenge to provide a suitable niche for the fabricated tissue constructs to undergo functional maturation. Bioreactors have emerged as a promising tool to enhance tissue maturation of the engineered constructs by providing physical/biological cues along with a controlled nutrient supply under dynamic in vitro conditions. Bioreactors provide an ambient microenvironment most appropriate for the development of functionally matured tissue constructs by promoting cell proliferation, differentiation, and maturation for transplantation and drug screening applications. Due to the huge cost and limited availability of commercial bioreactors, there is a need to develop strategies to make customized bioreactors. Additive manufacturing (AM) may be a viable tool to fabricate custom designed bioreactors with better efficiency and at low cost. In this review, we have extensively discussed the importance of bioreactors in functionalizing tissue engineered/3D bioprinted scaffolds for bone, cartilage, skeletal muscle, nerve, and vascular tissue. In addition, the importance and fabrication of customized 3D printed bioreactors for the maturation of tissue engineered constructs are discussed in detail. Finally, the current challenges and future perspectives in translating commercial and custom 3D printed bioreactors for clinical applications are outlined.

1 July 2025 in Bioactive Materials
Verified
Journal Article
Open access
RBRosalie Bordett
Rosalie Bordett
SASama Abdulmalik
Sama Abdulmalik
AZAllen Zennifer
Allen Zennifer
SWSuranji Wijekoon
Suranji Wijekoon
SSSai Sadhananth Srinivasan
Sai Sadhananth Srinivasan
Sangmesh KumbarSangmesh Kumbar
Sangmesh Kumbar
Large-gap peripheral nerve injuries (PNI) are often treated with autografts, allografts, or synthetic grafts to facilitate nerve regeneration, but these options are often limited in their availability or functionality. To address these issues, we developed ionically conductive (IC) nerve guidance conduits (NGCs) of sufficient biodegradability, mechanical strength, and bioactivity to support large-gap nerve regeneration. These chitosan-based NGCs release 4-aminopyridine (4-AP) from embedded halloysite nanotubes, and the NGC's IC properties enable transcutaneous electrical stimulation (ES) without invasive electrodes. In vitro, we found scaffolds with ES+4-AP synergistically enhanced Schwann cell adhesion, proliferation, and neurotrophin secretion, significantly improving axonal growth and neurite extension. In vivo, these scaffolds in large-gap PNI boosted neurotrophin levels, myelination, nerve function, and muscle weight while promoting angiogenesis and reducing fibrosis. Upregulated Trk receptors and PI3K/Akt and MAPK pathway highlight the regenerative potential. This study advances understanding of ES-mediated regeneration and supports innovative strategies for nerve and musculoskeletal repair.

31 July 2024 in International Journal of High Speed Electronics and Systems
Verified
Journal Article
Closed access
SASama Abdulmalik
Sama Abdulmalik
SWSuranji Wijekoon
Suranji Wijekoon
KDKhadija Basiru Danazumi
Khadija Basiru Danazumi
SSSai Sadhananth Srinivasan
Sai Sadhananth Srinivasan
LVLaxmi Vobbineni
Laxmi Vobbineni
Sangmesh KumbarSangmesh Kumbar
Sangmesh Kumbar

18 July 2025 in International Journal of High Speed Electronics and Systems
Verified
Journal Article
Closed access
SSSai Sadhananth Srinivasan
Sai Sadhananth Srinivasan
SWSuranji Wijekoon
Suranji Wijekoon
AZAllen Zennifer
Allen Zennifer
SASama Abdulmalik
Sama Abdulmalik
Sangmesh KumbarSangmesh Kumbar
Sangmesh Kumbar